Dr. Reddy's Laboratories Limited (BOM:500124)
India · Delayed Price · Currency is INR 1,313.05
+21.90 (1.70%)
At close: Mar 5, 2026
Dr. Reddy's Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 346,325 | 325,535 | 279,164 | 245,879 | 214,391 | 189,722 | |
Revenue Growth (YoY) | 11.06% | 16.61% | 13.54% | 14.69% | 13.00% | 8.66% |
Cost of Revenue | 136,943 | 135,107 | 115,557 | 106,536 | 100,551 | 86,645 |
Gross Profit | 209,382 | 190,428 | 163,607 | 139,343 | 113,840 | 103,077 |
Selling, General & Admin | 29,043 | 93,870 | 77,201 | 68,026 | 62,081 | 54,650 |
Depreciation & Amortization Expenses | 8,908 | - | - | - | - | - |
Research & Development | 12,350 | 27,380 | 22,873 | 19,381 | 17,482 | 16,541 |
Other Operating Expenses | 34,940 | 1,693 | 3 | 699 | 7,562 | 8,588 |
Operating Income | 124,141 | 67,485 | 63,530 | 51,237 | 26,715 | 23,298 |
Interest Income | - | 12,277 | 9,699 | 7,134 | 5,196 | 4,276 |
Interest Expense | -1,486 | -2,829 | -1,711 | -1,428 | -958 | -970 |
Other Non-Operating Income (Expense) | 3,417 | 14,575 | 4,346 | 6,277 | 3,464 | 1,462 |
Total Non-Operating Income (Expense) | 1,931 | 24,023 | 12,334 | 11,983 | 7,702 | 4,768 |
Pretax Income | 124,132 | 76,784 | 71,870 | 60,367 | 32,298 | 26,413 |
Provision for Income Taxes | 7,610 | 19,539 | 16,186 | 15,300 | 8,730 | 9,175 |
Net Income | 56,584 | 56,544 | 55,684 | 45,067 | 22,865 | 16,758 |
Minority Interest in Earnings | 125 | -484 | 147 | 370 | 703 | 480 |
Net Income to Common | 56,584 | 56,544 | 55,684 | 45,067 | 22,865 | 16,758 |
Net Income Growth | 5.36% | 1.54% | 23.56% | 97.10% | 36.44% | -11.51% |
Shares Outstanding (Basic) | 833 | 833 | 832 | 830 | 829 | 829 |
Shares Outstanding (Diluted) | 833 | 834 | 834 | 832 | 832 | 832 |
Shares Change (YoY) | 24.69% | 0.07% | 0.19% | 0.03% | 0.01% | 0.14% |
EPS (Basic) | 67.96 | 67.89 | 66.93 | 54.28 | 28.42 | 20.79 |
EPS (Diluted) | 67.96 | 67.79 | 66.80 | 54.17 | 28.34 | 20.73 |
EPS Growth | -45.49% | 1.48% | 23.32% | 91.16% | 36.70% | -11.71% |
Free Cash Flow | 36,656 | 18,924 | 29,030 | 47,552 | 13,448 | 25,962 |
Free Cash Flow Growth | 93.70% | -34.81% | -38.95% | 253.60% | -48.20% | 3.86% |
Free Cash Flow Per Share | - | - | 34.83 | 57.16 | 16.17 | 31.22 |
Dividends Per Share | 8.000 | 8.000 | 8.000 | 8.000 | 6.000 | 5.000 |
Dividend Growth | - | - | - | 33.33% | 20.00% | - |
Gross Margin | 27.42% | 58.50% | 58.61% | 56.67% | 53.10% | 54.33% |
Operating Margin | 2.80% | 20.73% | 22.76% | 20.84% | 12.46% | 12.28% |
Profit Margin | 16.21% | 17.58% | 19.95% | 18.33% | 10.99% | 9.09% |
FCF Margin | 10.58% | 5.81% | 10.40% | 19.34% | 6.27% | 13.68% |
EBITDA | 29,244 | 84,495 | 78,371 | 63,872 | 38,539 | 36,094 |
EBITDA Margin | 8.44% | 25.96% | 28.07% | 25.98% | 17.98% | 19.02% |
EBIT | 124,141 | 67,485 | 63,530 | 51,237 | 26,715 | 23,298 |
EBIT Margin | 2.80% | 20.73% | 22.76% | 20.84% | 12.46% | 12.28% |
Effective Tax Rate | 19.46% | 25.45% | 22.52% | 25.34% | 27.03% | 34.74% |
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.